466 related articles for article (PubMed ID: 17378367)
1. beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals.
Kawaguchi H; Masuo K; Katsuya T; Sugimoto K; Rakugi H; Ogihara T; Tuck ML
Hypertens Res; 2006 Dec; 29(12):951-9. PubMed ID: 17378367
[TBL] [Abstract][Full Text] [Related]
2. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Circulation; 2005 Jun; 111(25):3429-34. PubMed ID: 15956122
[TBL] [Abstract][Full Text] [Related]
3. Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.
Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2005 Nov; 18(11):1508-16. PubMed ID: 16280290
[TBL] [Abstract][Full Text] [Related]
4. High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals.
Masuo K; Katsuya T; Sugimoto K; Kawaguchi H; Rakugi H; Ogihara T; Tuck ML
Hypertens Res; 2007 Jun; 30(6):503-11. PubMed ID: 17664853
[TBL] [Abstract][Full Text] [Related]
5. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2005 Jul; 18(7):1009-14. PubMed ID: 16054001
[TBL] [Abstract][Full Text] [Related]
6. Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation.
Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2006 Oct; 19(10):1084-91. PubMed ID: 17027833
[TBL] [Abstract][Full Text] [Related]
7. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
[TBL] [Abstract][Full Text] [Related]
8. The frequency of Trp64Arg polymorphism of the beta3-adrenergic receptor gene in healthy and obese Hungarian children and its association with cardiovascular risk factors.
Erhardt E; Czakó M; Csernus K; Molnár D; Kosztolányi G
Eur J Clin Nutr; 2005 Aug; 59(8):955-9. PubMed ID: 15942638
[TBL] [Abstract][Full Text] [Related]
9. Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study.
Ukkola O; Rankinen T; Weisnagel SJ; Sun G; Pérusse L; Chagnon YC; Després JP; Bouchard C
Metabolism; 2000 Aug; 49(8):1063-70. PubMed ID: 10954027
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of the metabolic syndrome in adolescents: minor role of the Trp64Arg beta3-adrenergic receptor gene variant.
Porto PI; García SI; Dieuzeide G; González C; Landa MS; Pirola CJ
Pediatr Res; 2004 May; 55(5):836-41. PubMed ID: 14739355
[TBL] [Abstract][Full Text] [Related]
11. Lys418Asn polymorphism of the alpha2-adrenoceptor gene relates to serum uric acid levels but not to insulin sensitivity.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Hypertension; 2005 Jul; 46(1):144-50. PubMed ID: 15939803
[TBL] [Abstract][Full Text] [Related]
12. Circulating ghrelin levels in obese women: a possible association with hypertension.
Oner-Iyidoğan Y; Koçak H; Gürdöl F; Oner P; Issever H; Esin D
Scand J Clin Lab Invest; 2007; 67(5):568-76. PubMed ID: 17763194
[TBL] [Abstract][Full Text] [Related]
13. Relation of Trp64Arg polymorphism of beta 3-adrenergic receptor gene to adipocytokines and fat distribution in obese patients.
de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
Ann Nutr Metab; 2008; 52(4):267-71. PubMed ID: 18617734
[TBL] [Abstract][Full Text] [Related]
14. Relation of Trp64Arg polymorphism of beta3-adrenoreceptor gene with cardiovascular risk factors in presurgical morbidly obese patients.
de Luis DA; Aller R; Izaola O; Gonzalez-Sagrado M; Conde R
Arch Med Res; 2008 Nov; 39(8):791-5. PubMed ID: 18996293
[TBL] [Abstract][Full Text] [Related]
15. ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1.
Daghestani M; Daghestani M; Daghistani M; Eldali A; Hassan ZK; Elamin MH; Warsy A
Lipids Health Dis; 2018 Mar; 17(1):58. PubMed ID: 29587766
[TBL] [Abstract][Full Text] [Related]
16. Different mechanisms in weight loss-induced blood pressure reduction between a calorie-restricted diet and exercise.
Masuo K; Rakugi H; Ogihara T; Lambert GW
Hypertens Res; 2012 Jan; 35(1):41-7. PubMed ID: 21814218
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma angiotensinII, leptin and arterial blood pressure.
Al-Hazimi AM; Syiamic AY
Saudi Med J; 2004 Sep; 25(9):1193-8. PubMed ID: 15448764
[TBL] [Abstract][Full Text] [Related]
18. An association between the Trp64Arg polymorphism in the beta3-adrenergic receptor gene and endometrial cancer and obesity.
Babol K; Przybylowska K; Lukaszek M; Pertynski T; Blasiak J
J Exp Clin Cancer Res; 2004 Dec; 23(4):669-74. PubMed ID: 15743038
[TBL] [Abstract][Full Text] [Related]
19. Association of cholecystokinin 1 receptor and beta3-adrenergic receptor polymorphisms with midlife weight gain.
Koda M; Ando F; Niino N; Shimokata H; Miyasaka K; Funakoshi A
Obes Res; 2004 Aug; 12(8):1212-6. PubMed ID: 15340101
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure.
Lambert E; Straznicky N; Eikelis N; Esler M; Dawood T; Masuo K; Schlaich M; Lambert G
J Hypertens; 2007 Jul; 25(7):1411-9. PubMed ID: 17563563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
